WHO experts: China's Sinopharm and Sinovac vaccines can prevent 'Omicron' infection from becoming seriously.
Dubai: The United Arab Emirates's newspaper quoted an expert at the World Health Organization (WHO) as saying that the Chinese vaccines Sinopharm and Sinovac are effective against serious illnesses caused by the COVID-19 mutation. New Omicron. This is according to the Chinese newspaper CGTN on Thursday evening, January 6, 2022.
"More and more evidence is showing that Omicron affects the upper respiratory tract, causing milder symptoms than the virus," said Abdi Mahamud, a WHO emergency response specialist for the pandemic. Previous categories. This is in line with the recent findings of British and South African scientists that Omicron can transmit faster than previous viruses, especially Delta, but the severity of the disease after infection. This is lower than the Delta.
The United Arab Emirates (UAE) has also just approved the emergency use of the newly enhanced vaccine by Chinese company Sinpharm, which will be used as a "boosting dose" for the Arab country. According to the UAE Ministry of Health, the new Chinese vaccine Sinopharm will strengthen the immune system against the new mutated virus safely.
